Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT00716092
Eligibility Criteria:
Inclusion criteria:
* Male and female patients with a diagnosis of type 2 diabetes mellitus and previously treated with not more than one drug
* Glycosylated haemoglobin A1 (HbA1c) 6.5 to 10.0% at Start of Run-in
Exclusion criteria:
* Myocardial infarction, stroke or transient ischemic attack "TIA" within 6 months prior to informed consent
* Impaired hepatic function
* Renal insufficiency with a creatinine clearance \< 50 mL/min
* Treatment with rosiglitazone, pioglitazone, glucagon like peptide 1 (GLP-1) analogues, insulin, dipeptidyl peptidase 4 (DPP-4) inhibitors or anti-obesity drugs 3 months prior to informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00716092
Study Brief:
Protocol Section:
NCT00716092